A new shield from the double-edged sword of reperfusion in STEMI

Affiliations

¹ The Cardiovascular Center and Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA, USA nkapur@tuftsmedicalcenter.org.
² The Cardiovascular Center and Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA, USA.

Editorial

Navin K Kapur et al. Eur Heart J. 2015.

. 2015 Nov 21;36(44):3058-60.

doi: 10.1093/eurheartj/ehv438. Epub 2015 Sep 8.

¹ The Cardiovascular Center and Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA, USA nkapur@tuftsmedicalcenter.org.
² The Cardiovascular Center and Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA, USA.

No abstract available

Comment on

Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trial.
Eitel I, Stiermaier T, Rommel KP, Fuernau G, Sandri M, Mangner N, Linke A, Erbs S, Lurz P, Boudriot E, Mende M, Desch S, Schuler G, Thiele H. Eitel I, et al. Eur Heart J. 2015 Nov 21;36(44):3049-57. doi: 10.1093/eurheartj/ehv463. Epub 2015 Sep 17. Eur Heart J. 2015. PMID: 26385956 Clinical Trial.